47 results
8-K
EX-99.1
TSVT
2seventy bio Inc
30 Jan 24
2seventy bio Announces New Strategic Path Forward
7:48am
, clinical manufacturing capabilities, and related platform technologies.
“Together with the Board, we have completed a thorough assessment of our
8-K
EX-99.1
vdq7vihc5082o
12 Dec 23
Regulation FD Disclosure
7:25am
8-K
EX-99.1
2xys9k
12 Sep 23
2seventy bio Announces Strategic Restructuring to Prioritize Growth of Abecma, Streamline Pipeline Advancement and Preserve Financial Runway
7:13am
8-K
EX-99.1
9bdsi2ukwwpac 4c
14 Jun 23
Unleash Time 2seventy bio company presentation June 2023
7:02am
8-K
EX-99.1
0h04ibpb6g17i
19 May 23
Regulation FD Disclosure
6:07am
8-K
EX-99.2
mlo n616f
19 May 23
Regulation FD Disclosure
6:07am
PRE 14A
3nhazbv
18 Apr 23
Preliminary proxy
5:21pm
8-K
EX-99.1
2gezerr01tonkerc0s
17 Apr 23
Other Events
7:36am
424B5
c2k02ad7bha31har
18 Nov 22
Prospectus supplement for primary offering
4:31pm
S-3
6v9h8q
7 Nov 22
Shelf registration
4:28pm
S-3
EX-4.5
28l89re0el1oi2037bj
7 Nov 22
Shelf registration
4:28pm